Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FURIN | P09958 | 20/20 | 0.81 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24872468 | 1.00 | FURIN (0.81) | FURIN | |
| SCHEMBL27031828 | 0.94 | FURIN (0.84) | FURIN | |
| SCHEMBL29927885 | 0.94 | FURIN (0.82) | FURIN | |
| SCHEMBL21550710 | 0.94 | FURIN (0.84) | FURIN | |
| SCHEMBL21551350 | 0.94 | FURIN (0.82) | FURIN | |
| SCHEMBL21551349 | 0.94 | FURIN (0.82) | FURIN | |
| SCHEMBL21553780 | 0.92 | FURIN (0.80) | FURIN | |
| SCHEMBL21553779 | 0.92 | FURIN (0.80) | FURIN | |
| SCHEMBL29928725 | 0.92 | FURIN (0.80) | FURIN | |
| SCHEMBL21551529 | 0.92 | FURIN (0.88) | FURIN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115666567-A | Furin inhibitors for the treatment of coronavirus infection | BP资产V股份有限公司 | 2023-01-31 | — | — | CN | claimed |
| WO-2021097002-A1 | USE OF PYRIDYLOXYPYRIMIDINES FOR TREATING INFECTIOUS DISEASES | BP ASSET V, INC. (US) | 2021-05-20 | — | — | WO | claimed |
| CN-112384509-A | Furin inhibitors | 葛兰素史密斯克莱知识产权发展有限公司 | 2021-02-19 | — | — | CN | claimed |
| US-20230011571-A1 | SMALL MOLECULE FURIN INHIBITORS FOR TREATING INFECTIOUS DISEASES | BP ASSET V, INC. (US) | 2023-01-12 | — | — | US | disclosed |
| CN-112384509-A | Furin inhibitors | 葛兰素史密斯克莱知识产权发展有限公司 | 2021-02-19 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230011571-A1 | SMALL MOLECULE FURIN INHIBITORS FOR TREATING INFECTIOUS DISEASES | FURIN, LGMN, PLAU | FURIN 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.